ALBERT
DELGADO-IRIBARREN GARCÍA-CAMPERO
Profesor asociado de Ciencias de la Salud
Publicaciones en las que colabora con ALBERT DELGADO-IRIBARREN GARCÍA-CAMPERO (23)
2023
2021
-
Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection
Clinical Microbiology and Infection, Vol. 27, Núm. 5, pp. 758-761
2019
-
Candidemia in solid organ transplant recipients in Spain: Epidemiological trends and determinants of outcome
Transplant Infectious Disease, Vol. 21, Núm. 6
-
Prevalence of submicroscopic malaria infection in immigrants living in Spain
Malaria Journal, Vol. 18, Núm. 1
2017
-
Carbapenem-resistant Citrobacter spp. isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 12, pp. 3283-3287
-
Epidemiology and prognosis of candidaemia in elderly patients
Mycoses, Vol. 60, Núm. 12, pp. 808-817
-
Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia
Clinical Microbiology and Infection, Vol. 23, Núm. 1, pp. 49.e1-49.e8
-
Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance
Clinical Microbiology and Infection, Vol. 23, Núm. 9, pp. 672.e1-672.e11
2016
-
Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain
Journal of Infection, Vol. 72, Núm. 2, pp. 152-160
-
Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score–derived analysis of a population-based, multicentre prospective cohort
Clinical Microbiology and Infection, Vol. 22, Núm. 8, pp. 733.e1-733.e8
2015
-
A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains
Clinical Microbiology and Infection, Vol. 21, Núm. 7, pp. 684.e1-684.e9
-
Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance
Journal of Infection, Vol. 71, Núm. 3, pp. 385-394
-
Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: RESULTS from a population-based surveillance in Spain
Clinical Microbiology and Infection, Vol. 21, Núm. 5, pp. 491.e1-491.e10
2014
-
Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: A population-based surveillance in Spain
Clinical Microbiology and Infection, Vol. 20, Núm. 4
2012
-
The undiagnosed cases of Clostridium difficile infection in a whole nation: Where is the problem?
Clinical Microbiology and Infection, Vol. 18, Núm. 7
2011
2010
-
AmpC β-lactamases in Escherichia coli: Emergence of CMY-2-producing virulent phylogroup D isolates belonging mainly to STs 57, 115, 354, 393, and 420, and phylogroup B2 isolates belonging to the international clone O25b-ST131
Diagnostic Microbiology and Infectious Disease, Vol. 67, Núm. 3, pp. 270-276
2006
-
Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions
Journal of Clinical Microbiology, Vol. 44, Núm. 7, pp. 2359-2366
2005
-
Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain
Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 5, pp. 2122-2125
2003
-
Escherichia coli y Klebsiella pneumoniae productores de betalactamasas de espectro extendido en hospitales españoles (Proyecto GEIH-BLEE 2000)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 21, Núm. 2, pp. 77-82